The Gamaleya Center has developed a version of “Sputnik V” against the “delta” and “omicron”

The Gamaleya Center has developed a new version of the Sputnik V vaccine, which is adapted to the delta and omicron coronavirus strains. The original version of the vaccine “continues to show excellent results in preventing hospitalizations and deaths,” the center said.

The updated Sputnik V showed a reduction in viral load in the lungs of animals infected with the omicron BA.5 variant, the developers say. “The composition of the drug takes into account the L-452-R mutation, which is present in the omicron BA.5 variant, but is absent in the BA.1 variant,” the Russian Direct Investment Fund said (quoted from TASS).

In August, the head of the Gamaleya Center Alexander Gintsburg told on the creation of the subvalent platform “Sputnik V” against three new types of “omicron” (BA.1, BA.2, BA.5). He expectsthat the incidence of COVID-19 in the country will rise to the levels of last winter. Over the past week, the number of people infected with the virus in Russia increased by 38%.

About the situation with the pandemic – in the material “Kommersant” “COVID is left with a nose”.